Close Menu
Home » CRISPR Researchers Engineer More Efficient Cas12a Variants for Genetic, Epigenetic, Base Editing

CRISPR Researchers Engineer More Efficient Cas12a Variants for Genetic, Epigenetic, Base Editing

Feb 11, 2019
|
staff reporter

NEW YORK (GenomeWeb) – In a study published today in Nature Biotechnology, researchers in Keith Joung's lab at Massachusetts General Hospital described their efforts to engineer enhanced variants of the Cas12a nuclease that can target a wider range of protospacer adjacent motifs (PAM), have enhanced editing activity, and have reduced off-target effects.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Scan

Collins to Avoid 'Manels'

US National Institutes of Health Director Francis Collins says he will avoid male-only speaker panels.

Patient Dies Following Fecal Transplant

Two patients fell ill, and one subsequently died, following a fecal microbiome transplant that harbored multi-drug-resistant bacteria, according to the New York Times.

From Pigs to Monkeys

Technology Review reports that eGenesis is testing whether organs from genetically modified pigs can be transplanted into monkeys.

This Week in Science

In Science this week: almond reference genome, and more.

What's Popular?

In Gene Silencing/Gene Editing

  1. GlaxoSmithKline, UC's Doudna Establish $67M Genomics, CRISPR Research Lab

  2. CRISPR DNA Base Editors Cause Tens of Thousands of Off-Target RNA Mutations

  3. Ginkgo Bioworks Takes $80M Stake in Synlogic as Part of Platform Collaboration

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.